INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

79,733 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
OD
Oddie Andrew DavidCHIEF INTERNATIONAL OFFICER
FNKOFunko, Inc.
Grant or award
A—
123.8K sh
Mar 17, 2026Mar 19, 2026
Page 1332 of 1994
← PrevNext →
traded Mar 17, 2026
+2d
SEC Form 4

Evidence

5
PK
Phan KongChief Accounting Officer
CFLTConfluent, Inc.
Disposition to issuer
D—
149.8K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
SR
Sivaram RohanCHIEF FINANCIAL OFFICER
CFLTConfluent, Inc.
Disposition to issuer
D—
319.3K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
Narkhede NehaDirector
CFLTConfluent, Inc.
Disposition to issuer
D—
1.08M sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Grant or award
A—
123.8K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
CL
Caimi LaraDirector
CFLTConfluent, Inc.
Disposition to issuer
D—
8,302 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
GM
Gray Jonice MDirector
VACMARRIOTT VACATIONS WORLDWIDE Corp
Grant or award
A—
138 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

5
CL
Caimi LaraDirector
CFLTConfluent, Inc.
Disposition to issuer
D—
186.1K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
KJ
Kreps Edward JayDirector, CHIEF EXECUTIVE OFFICER
CFLTConfluent, Inc.
Disposition to issuer
D—
1.00M sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
Narkhede NehaDirector
CFLTConfluent, Inc.
Disposition to issuer
D—
377.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
KJ
Kreps Edward JayDirector, CHIEF EXECUTIVE OFFICER
CFLTConfluent, Inc.
Disposition to issuer
D—
2.35M sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
Narkhede NehaDirector
CFLTConfluent, Inc.
Disposition to issuer
D—
629.4K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
KJ
Kreps Edward JayDirector, CHIEF EXECUTIVE OFFICER
CFLTConfluent, Inc.
Disposition to issuer
D—
1.22M sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
KJ
Kreps Edward JayDirector, CHIEF EXECUTIVE OFFICER
CFLTConfluent, Inc.
Disposition to issuer
D—
301.7K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
Narkhede NehaDirector
CFLTConfluent, Inc.
Disposition to issuer
D—
1,787 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
KJ
Kreps Edward JayDirector, CHIEF EXECUTIVE OFFICER
CFLTConfluent, Inc.
Disposition to issuer
D—
150.0K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
SR
Sivaram RohanCHIEF FINANCIAL OFFICER
CFLTConfluent, Inc.
Disposition to issuer
D—
212.7K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
RH
Rubenstein Andrew H.Director, CEO and President, 10% Owner
ACELAccel Entertainment, Inc.
Open-market sale · 10b5-1 plan
SELL$44K
3,938 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
Narkhede NehaDirector
CFLTConfluent, Inc.
Disposition to issuer
D—
8,302 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

4
TR
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
GKOSGLAUKOS Corp
Tax withholding · 10b5-1 plan
F$61K
614 sh
Mar 16, 2026Mar 19, 2026
traded Mar 16, 2026
+3dSEC Form 4

Evidence

4
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

4
SJ
Scaringe Robert JDirector, Chief Executive Officer
RIVNRivian Automotive, Inc. / DE
Open-market sale · 10b5-1 plan
SELL$272K
17.4K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

4
CR
Chatwani RobertPresident General Mgr, Growth
DOCUDOCUSIGN, INC.
Open-market sale · 10b5-1 plan
SELL$144K
3,085 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

4
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

4
CR
Chatwani RobertPresident General Mgr, Growth
DOCUDOCUSIGN, INC.
Open-market sale · 10b5-1 plan
SELL$64K
1,395 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

4
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M$2.53M
3.21M sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

4
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

3
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M—
1.79M sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

2
PJ
Peterson JustinChief Technology Officer
TWTradeweb Markets Inc.
Tax withholding · 10b5-1 plan
F$157K
1,241 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
BS
Blake SarahSVP, Chief Accounting Officer
VGVenture Global, Inc.
Grant or award · 10b5-1 plan
A—
500.0K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
PJ
Peterson JustinChief Technology Officer
TWTradeweb Markets Inc.
Grant or award · 10b5-1 plan
A—
3 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
1,365 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
37.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$2,989
1,365 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

0
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Grant or award · 10b5-1 plan
A—
500.0K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence